The Effect of Interactive Games on Children Receiving Intravenous Injection
The Effect of Somatosensory Interactive Games on the Pain, Fear and Negative Emotions of Children Receiving Intravenous Injection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 640
- National Taiwan University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- 2-7 years old, normal consciousness, preschool children who need intravenous injection.
- 7-12 years old, normal consciousness, school-age children who need intravenous injection.
- Parents of children need to be conscious and able to talk in Chinese.
Exclusion criteria:
- 2-7 years old preschool children with developmental delay, epilepsy, heart disease, chemotherapy, visual and hearing impaired, obese, and have received more than 2 intravenous injections.
- 7-12-year-old school-age children with developmental delay, epilepsy, heart disease, chemotherapy, visual and hearing impaired, obese, and have received more than 2 intravenous injections.
- The child's parents cannot express and communicate effectively.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: The somatosensory interactive game
The somatosensory interactive game, an independent nursing intervention, promotes pain relief on the experimental group.
|
The somatosensory interactive game, an independent nursing intervention, promotes pain relief for preschool children.
|
|
Experimental: A VR (virtual reality) game
A VR (virtual reality) game promotes pain relief on the experimental group.
|
A VR (virtual reality) game environment promotes pain relief for school-age children.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in children's pain from baseline to after intravenous injection
Time Frame: O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
Using Wong-Baker Faces Pain Rating Scale to measure pain.
There are 6 faces in the Wong-Baker Pain Scale.
The first face represents a pain score of 0, and indicates "no hurt".
The second face represents a pain score of 2, and indicates "hurts a little bit."
The third face represents a pain score of 4, and indicates "hurts a little more".
The fourth face represents a pain score of 6, and indicates "hurts even more".
The fifth face represents a pain score of 8, and indicates "hurts a whole lot"; the sixth face represents a pain score of 10, and indicates "hurts worst."
Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the pain levels experienced by the children receiving intravenous injections.
|
O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
|
Changes in children's fear from baseline to after intravenous injection
Time Frame: O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
Using Children's Fear scale to measure the fear level.
Score the chosen face from 0 (the left-most face) to 4 (the last face).
This face [point to the left-most face] shows no anxiety at all, this faces shows a little bit more [point to second face from left], a bit more [sweep finger along scale], right up to extreme anxiety [point to the last face on the right].
Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the fear levels experienced by the children receiving intravenous injections.
|
O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
|
Changes in children's emotion from baseline to after intravenous injection
Time Frame: O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
Using Children's Emotional Management Scales to measure the emotion level.
The scale includes five observed emotional behavior categories, facial expression, vocalization, activity, interaction, and level of cooperation.
Each category is scored from 1-5 points, the lowest total score is 5 points, and the highest score is 25 points.
The higher the score, the more negative emotional behavior.
Nurses, pre-school children by the assistance of caregivers, and school-age children were asked to evaluate the emotion levels experienced by the children receiving intravenous injections.
|
O1 (before intervention); O2 (immediately after intravenous injection); O3 (1 day after intravenous injection)
|
|
semi-structed interviews
Time Frame: immediately after intravenous injection
|
After intravenous injection, a semi-structured qualitative interview was conducted with selected and their parent to understand the differences in experience before and after intervention.
|
immediately after intravenous injection
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Hui-Mei Chen, OTHERS, NTUH Yunlin Branch
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 202012054RINC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.